|
WHSC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.558400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.905400E-01 |
| Normal-vs-Stage2 |
4.629200E-01 |
| Normal-vs-Stage3 |
7.478000E-02 |
| Normal-vs-Stage4 |
4.407200E-01 |
| Stage1-vs-Stage2 |
5.743600E-01 |
| Stage1-vs-Stage3 |
1.804160E-02 |
| Stage1-vs-Stage4 |
3.247800E-01 |
| Stage2-vs-Stage3 |
6.787600E-02 |
| Stage2-vs-Stage4 |
2.246200E-01 |
| Stage3-vs-Stage4 |
5.282400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.902400E-01 |
| Normal-vs-AfricanAmerican |
2.539800E-01 |
| Normal-vs-Asian |
8.236200E-01 |
| Caucasian-vs-AfricanAmerican |
1.105040E-01 |
| Caucasian-vs-Asian |
3.502400E-01 |
| AfricanAmerican-vs-Asian |
2.925400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.331000E-01 |
| Normal-vs-Female |
7.735200E-01 |
| Male-vs-Female |
7.435200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.921000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.400200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.408000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.525800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.105400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.908800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.502400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.328600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.869600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.413400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.83100000000259E-05 |
| Classical-VS-Follicular |
1.834170E-02 |
| Classical-VS-Other |
5.835900E-02 |
| Classical-VS-Normal |
8.373200E-01 |
| Tall-VS-Follicular |
1.16999999999479E-06 |
| Tall-VS-Other |
8.444200E-01 |
| Tall-VS-Normal |
6.593100E-04 |
| Follicular-VS-Other |
3.462200E-03 |
| Follicular-VS-Normal |
4.502500E-02 |
| Other-VS-Normal |
7.438000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.266800E-01 |
| Normal-vs-N1 |
1.570970E-01 |
| N0-vs-N1 |
5.997500E-02 |
|
|
